Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-19
    E.g., 2018-09-19

Archive Search

2 results
12:00 AM, Feb 11, 2013  |  BioCentury | Emerging Company Profile

GeneCentric: Cancer sign-off

to an anti-angiogenesis drug, she said. The gene signature, also licensed from UNC, includes VEGF, angiopoietin-like 4
ANGPTL4) , adrenomedullin (ADM; AM) and solute carrier family 16 member 3 (SLC16A3) . Perou was …
12:00 AM, Dec 03, 2012  |  BioCentury | Emerging Company Profile

Lipigon: LPL protectorate

activity to about 60,000 ester bonds per minute. By contrast, in disease states, inhibitors including angiopoietin-like 4
ANGPTL4) and apolipoprotein C-III ( APOCIII ; APOC3 ) become overly active and cleave LPL into …